These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35505293)

  • 1. Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients.
    Guo H; Zhang M; Zhang N; Yin X; Cheng Y; Gu L; Wang X; Xiao J; Wang Y; Zou X; Zhuge Y; Zhang F
    BMC Gastroenterol; 2022 May; 22(1):213. PubMed ID: 35505293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential variceal pressure measurement by endoscopic needle puncture during maintenance sclerotherapy: the correlation between variceal pressure and variceal rebleeding.
    Hou MC; Lin HC; Kuo BI; Liao TM; Lee FY; Chang FY; Lee SD
    J Hepatol; 1998 Nov; 29(5):772-8. PubMed ID: 9833915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A prognostic analysis of cirrhotic esophageal variceal bleeding treated with standardized endoscopic therapy].
    Dai YP; Gao Q
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):195-199. PubMed ID: 28482406
    [No Abstract]   [Full Text] [Related]  

  • 4. A Prospective Study of Endoscopic Injection Sclerotherapy and Endoscopic Variceal Ligation in the Treatment of Esophageal Varices.
    Ali SM; Wu S; Xu H; Liu H; Hao J; Qin C
    J Laparoendosc Adv Surg Tech A; 2017 Apr; 27(4):333-341. PubMed ID: 28221819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis.
    Wu L; Fang QQ; Huang XQ; Xue CY; Rao CY; Luo JJ; Xu PJ; Chen Y; Chen S; Li F
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):301-308. PubMed ID: 36795329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding.
    Wang J; Tian XG; Li Y; Zhang CQ; Liu FL; Cui Y; Liu JY
    World J Gastroenterol; 2013 Feb; 19(5):706-14. PubMed ID: 23430149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study.
    Madonia S; D'Amico G; Traina M; Gatto G; Virdone R; Salamone N; Licata A; Tarantino I; Pagliaro L
    Dig Liver Dis; 2000 Dec; 32(9):782-91. PubMed ID: 11215559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation.
    Hou MC; Lin HC; Lee FY; Chang FY; Lee SD
    J Hepatol; 2000 Feb; 32(2):202-8. PubMed ID: 10707859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopic sclerotherapy: a prospective randomized study.
    Bhargava DK; Pokharna R
    Am J Gastroenterol; 1997 Jun; 92(6):950-3. PubMed ID: 9177508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study.
    Zheng J; Zhang Y; Li P; Zhang S; Li Y; Li L; Ding H
    BMC Gastroenterol; 2019 Feb; 19(1):32. PubMed ID: 30782139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of purple sign for predicting rebleeding events in cirrhotic patients following endoscopic selective varices devascularization].
    Wu Y; Chen M; Huang M; Liao G; Tang S; Zheng H; Li Y; Peng B; Zheng X; Pan S; Hou J; Chen B
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1822-1827. PubMed ID: 35012914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy.
    Wang J; Wang AJ; Li BM; Liu ZJ; Chen L; Wang H; Shi F; Zhu X
    J Clin Gastroenterol; 2014; 48(10):870-7. PubMed ID: 24296420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The association between portal vein thrombosis and rebleeding after non-urgent endoscopic treatment of esophagogastric varices].
    Li JX; Li ZJ; Zhang HM; Xu SS; Quan RZ; Zhang H; Lu MM; Wang XY; Ma S; Mi J; Ding H; Li XL
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(9):682-689. PubMed ID: 38418167
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre.
    Mosli MH; Aljudaibi B; Almadi M; Marotta P
    Saudi J Gastroenterol; 2013; 19(4):152-9. PubMed ID: 23828744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.
    Zhang H; Xiao J; Tu J; Zhang M; Zhang F; Yin Q; Zhuge Y
    Eur J Gastroenterol Hepatol; 2021 May; 33(5):752-761. PubMed ID: 33731589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variceal recurrence, rebleeding rates and alterations in clinical and laboratory parameters following post-variceal obliteration using endoscopic sclerotherapy.
    Krishnan A; Srinivasan V; Venkataraman J
    J Dig Dis; 2012 Nov; 13(11):596-600. PubMed ID: 23107447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic injection sclerotherapy of bleeding oesophageal varices: a retrospective analysis.
    Kassa E
    Ethiop Med J; 1997 Jan; 35(1):13-22. PubMed ID: 9293143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
    Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
    Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.